Canada markets open in 1 hour 34 minutes

Genix Pharmaceuticals Corporation (GENX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.06000.0000 (0.00%)
At close: 11:38AM EDT
Full screen
Previous Close0.0600
Open0.0700
Bid0.0600 x N/A
Ask0.0800 x N/A
Day's Range0.0600 - 0.0700
52 Week Range0.0200 - 0.0800
Volume9,000
Avg. Volume14,212
Market Cap3.553M
Beta (5Y Monthly)-0.51
PE Ratio (TTM)N/A
EPS (TTM)-0.0700
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Simply Wall St.

    Genix Pharmaceuticals First Quarter 2024 Earnings: CA$0.001 loss per share (vs CA$0.004 loss in 1Q 2023)

    Genix Pharmaceuticals ( CVE:GENX ) First Quarter 2024 Results Key Financial Results Net loss: CA$59.1k (loss narrowed...

  • Newsfile

    Genix Announces TSX-V Approval of Warrant Amendments

    Vancouver, British Columbia--(Newsfile Corp. - February 6, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that pursuant to its news release of January 18, 2024, the TSX Venture Exchange has approved the Company's application to amend both the exercise price and the warrant accelerator terms, in addition to extending the expiry dates of 3,354,945 previously issued and outstanding warrants (the "Warrants").The current exercise price of th

  • Newsfile

    Genix Announces Warrant Repricing and Seeks Extension

    Vancouver, British Columbia--(Newsfile Corp. - January 18, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has made an application to the TSX Venture Exchange (the "Exchange") to amend the exercise price, the warrant accelerator terms and extend the expiry date of 3,354,945 previously issued and outstanding warrants (the "Warrants").The Corporation is proposing to reduce the exercise price of the warrants from $0.30 per